Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Hameln, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Investigating advanced treatments for HER2-negative breast cancer, with specific focus on patients carrying genetic mutations and hormone receptor-positive cases.
Research includes evaluation of targeted therapies like Olaparib for adjuvant treatment and Abemaciclib in combination with endocrine therapy.
Comprehensive research focusing on personalized treatment approaches for breast cancer patients, evaluating survival rates and disease progression.
Studies examine effectiveness in both early-stage and metastatic disease scenarios, with particular attention to treatment timing and combinations.
Investigation of hormone-based treatments for breast cancer, including studies on treatment resistance and optimal therapy timing.
Research includes innovative approaches to side effect management and monitoring of treatment effectiveness in different patient populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
